ArticleLeukemia2026

HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia.

Lianjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.